Feasibility
Studies currently in Feasibility
Embedded Files
Last content update -Â 4th December 2025
Please contact the Cancer Research Team for more information
All Specialties
No trials currently in feasibility
No trials currently in feasibility
BLADDER
No trials currently in feasibility
No trials currently in feasibility
BREAST
No trials currently in feasibility
No trials currently in feasibility
COLORECTAL
No trials currently in feasibility
No trials currently in feasibility
GYNAE
MK2870-022
MK2870-022
Specialty: Gynae
PI: Prof. Dennis Hadjiyiannakis
CPMS No: 368839
Estimated Opening: February/March 2026
Description: A Phase 3, Randomized, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment With or Without Bevacizumab Versus Standard of Care After Second-line Platinum-based Doublet Chemotherapy in Participants With Platinum-sensitive Recurrent Ovarian Cancer (TroFuse-022/ENGOT-ov84/GOG-3103)
Head & Neck
No trials currently in feasibility
No trials currently in feasibility
Lung
BNT327-03
BNT327-03
Specialty: Lung
PI: Dr Amin Ali
CPMS No: 64727
Estimated Opening: December 2025
Description: Safety and effectiveness of BNT327, an investigational therapy in combination with chemotherapy for patients with untreated small-cell lung cancer
Multiple Specialties
No trials currently in feasibility
No trials currently in feasibility
PROSTATE
ELIPSE
ELIPSE
Speciality: Prostate
PI: Mr Michal Smolski
CPMS No: 63289
Estimated Opening: TBC 2026
Description: A randomised controlled trial comparing the clinical and cost-effectiveness of lymph node removal in patients undergoing curative surgery for localised high-risk Prostate Cancer.
PASenger
PASenger
Speciality: Prostate
PI: Prof. Omi Parikh
CPMS No: 69781
Estimated Opening: February 2026
Description: A Phase 3 Randomized, Open-label Study of JNJ-78278343, a T Cell-redirecting agent targeting Human Kallikrein 2, with Docetaxel Versus Docetaxel for Metastatic Castration-Resistant Prostate Cancer
RADIOTHERAPY
No trials currently in feasibility
No trials currently in feasibility
RENAL
No trials currently in feasibility
No trials currently in feasibility
SKIN
No trials currently in feasibility
No trials currently in feasibility
Supportive and Palliative Care
No trials currently in feasibility
No trials currently in feasibility
Teens & Young Adults (TYA)
No trials currently in feasibility
No trials currently in feasibility
UPPER GI
Protieus
Protieus
Specialty: Upper GI
PI: Dr Catherine Mitchell
IRAS: 329646
Estimated Opening: TBC 2026
Description: A Randomised Phase 2 Trial Comparing Proton versus Photon Based Neoadjuvant Chemoradiation, followed by Adjuvant Immunotherapy, in Oesophageal Cancer.
Report abuse